Alendronate Sodium Tablet
Product Images NDC 70518-0033

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 70518-0033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 01

Chemical structure of alendronate sodium showing the molecular arrangement including phosphonate groups, hydroxyl groups, and an aminoalkyl side chain with associated sodium and water molecules.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 02

A line chart titled 'Cumulative Incidence of Hip Fractures in the Three-Year Study of FIT' showing cumulative incidence (%) over time in months (0 to 36). It compares hip fracture incidence between patients treated with Alendronate Sodium and a placebo, with lower incidence shown for Alendronate Sodium throughout the study period.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 03

A bar chart showing the increase in bone mineral density (BMD) in postmenopausal women treated with Alendronate Sodium 10 mg/day over three years. The BMD % increase is shown for three anatomical sites: Lumbar Spine, Femoral Neck, and Trochanter, comparing U.S. and Multinational study results with error bars representing standard error.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 04

Line charts comparing the effect of Alendronate Sodium 10 mg/day versus placebo on lumbar spine bone mineral density (BMD) percent change from baseline in postmenopausal women over 36 months. One chart shows data from a US study and the other from a multinational study, both depicting mean BMD percent change with standard error over time.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 05

A figure titled 'Osteoporosis Prevention Studies in Postmenopausal Women' showing two bar charts. The charts depict the change in Bone Mineral Density (BMD) from baseline over 2-year and 3-year studies. BMD percent change with standard error is plotted for lumbar spine, femoral neck, trochanter, and total body regions comparing Alendronate Sodium 5 mg/day versus placebo groups.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 06

A bar chart titled 'Studies in Glucocorticoid-Treated Patients Increase in BMD Alendronate Sodium 5 mg/day at One Year' comparing percentage increase in bone mineral density (BMD) relative to placebo at lumbar spine, femoral neck, and trochanter regions. The chart shows data for two groups: U.S. and Multinational, with Multinational consistently having higher BMD increases across the three regions.*

FDA Label Image

1203dd0c 809a 4409 B948 B5e816b8a63a 07

A line chart depicting the effect of Alendronate Sodium 40 mg/day versus Placebo and Etidronate 400 mg/day on serum alkaline phosphatase levels in patients with Paget's Disease of Bone. The y-axis shows the mean percentage change from baseline serum alkaline phosphatase, and the x-axis shows time in months up to 6 months, with different lines representing placebo, Etidronate, and two Alendronate Sodium studies (multinational and U.S.).*

FDA Label Image

Mm2 (Alendronate Sodium 70mg 70518 0033 01)

Alendronate Sodium 70 mg tablets packaging label showing quantity of 12 tablets. Label includes manufacturer RemedyRepack Inc. and source manufacturer Cipla USA, Inc., Miami, FL. Directions advise to see package insert. Storage conditions specify 20-25°C with permitted excursions. Contains barcode and QR code.*

FDA Label Image

Remedy_label (Remedy Label)

Alendronate Sodium 70 mg oral tablets in a 12-count package. The label shows the proprietary name, strength, dosage form, and quantity. It is repackaged by RemedyRepack Inc. with original manufacturing by Cipla USA, Inc. Directions indicate to see the package insert, with storage temperature guidelines included. The label features a barcode and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.